CHICAGO, July 8, 2024
/PRNewswire/ -- The global DNA diagnostics market is poised
for substantial growth, projected to reach USD 21.2 billion by 2029, up from USD 13.3 billion in 2024, with a compound annual
growth rate (CAGR) of 9.7%. Key drivers include technological
advancements in DNA diagnostics, rising demand for personalized
medicine, and early disease detection in developing nations. Major
market players like Illumina, F. Hoffmann-La Roche Ltd., and Abbott
Laboratories are heavily investing in research and development,
enhancing diagnostic capabilities. However, ethical concerns
surrounding privacy and the emergence of alternative diagnostic
technologies pose challenges. Opportunities lie in advancements in
bioinformatics and artificial intelligence, revolutionizing genomic
analysis and enabling more precise healthcare solutions. The market
is segmented by offering (reagents & kits leading in CAGR),
application (oncology testing driving growth), technology
(sequencing technology at highest CAGR), specimen (blood, serum,
and plasma dominate), and end-user (diagnostic laboratories hold
largest share). North America
currently leads the market, followed by Europe, with the Asia Pacific expected to witness the highest
growth, driven by increasing healthcare expenditure and advanced
infrastructure.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145577831
Browse in-depth TOC on "DNA Diagnostics
Market".
350 - Tables
48 - Figures
347 -
Pages
Market Leadership and Strategy
Illumina Inc. leads the DNA diagnostics market, leveraging its
expertise in sequencing and array-based solutions for genetic
analysis. The company's integrated systems, consumables, and
informatics platforms support comprehensive genetic analysis and
are pivotal in maintaining its market dominance. Illumina's
substantial investment in R&D ensures continuous innovation,
reinforcing its position as a leader in genomics.
Danaher Corporation's Market Impact
Danaher Corporation holds a significant share in the DNA
diagnostics market, offering molecular-based analytical
instruments, reagents, and software through its Diagnostics
segment. The company's expansive global network supports its
diverse product offerings, positioning Danaher as a key player in
the industry's competitive landscape.
F. Hoffmann-La Roche Ltd.'s Innovation and Influence
F. Hoffmann-La Roche Ltd. is a prominent player in the DNA
diagnostics market, renowned for its diagnostic products in areas
like HPV, hepatitis, and HIV. The company's commitment to
innovation and quality, particularly through its Diagnostics
Division, underscores its role in advancing DNA diagnostics and
setting industry benchmarks.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=145577831
Segment Analysis: Offerings and Technology
In the DNA diagnostics market, offerings are segmented into
reagents & kits, instruments, and services & software.
Reagents & kits dominated the market in 2023 due to their
recurring demand compared to instruments. Technology segments
include PCR, microarrays, sequencing technology, and others, with
PCR leading in 2023 due to its widespread adoption in genomics and
advancements like qPCR.
Specimen and Application Insights
The market is segmented by specimen (blood, serum, plasma;
urine; and others), with blood, serum, and plasma holding the
largest share in 2023, driven by advancements in diagnostic
technologies and increased prevalence of infectious diseases.
Application-wise, infectious disease diagnostics held the largest
market share in 2023, supported by the development of advanced
assays and rising disease incidences.
End Users and Regional Analysis
End users in the DNA diagnostics market include diagnostic
laboratories, hospitals and clinics, and others, with diagnostic
laboratories leading in 2023 due to higher test volumes and
strengthened healthcare infrastructures. Geographically,
North America led the market in
2023, followed by Europe and the
Asia Pacific, driven by factors
such as prevalence of infectious diseases, increased healthcare
spending, and advanced healthcare systems in these regions.
For more information, inquire now! Inquire Now
Related Reports:
Gene Expression Analysis Market
Respiratory Diagnostics Market
Nucleic Acid Isolation and Purification Market
Molecular Quality Controls Market
NGS Sample Preparation Market
Get access to the latest updates on DNA Diagnostics
Companies and DNA Diagnostics Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.com/news-releases/dna-diagnostics-market-set-to-reach-usd-21-2-billion-by-2029--driven-by-technological-advances-and-growing-demand--marketsandmarkets-302190608.html
SOURCE MarketsandMarkets